Dr. Carsten Schmelter was awarded by the German Ophthalmological Society for the publication:
„Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy“ in Journal of Clinical Medicine 2019
Anti-TNFα and Anti-IL-1β Monoclonal Antibodies Preserve BV-2 Microglial Homeostasis Under Hypoxia...
Correlation of Functional and Structural Outcomes with Serum Antibody Profiles in Patients with...
Lab Hero Award 2023 Dr. Caroline Manicam is Winner of the Lab Leader category from a total of 160...
Adaptive responses of neuronal cells to chronic endoplasmic reticulum (ER) stress. Pham TNM,...
EVER AWARD The Scientific Committee of EVER 2023 awarded Dr. Caroline Manicam for the Best Poster...
EVER AWARD The Scientific Committee of EVER 2023 awarded Dr. Natarajan Perumal for the Best Poster...
Glaucoma Research Award 2023 Jeff Kristian Nzogang Fomo, MSc. was awarded from the Scientific...
Dr. Carsten Schmelter was awarded by the German Ophthalmological Society for the publication:
„Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy“ in Journal of Clinical Medicine 2019